Efficacy of an adjusted treatment strategy on the management and in-hospital outcome of patients with STEMI during the COVID-19 pandemic
Jing Wang
Inam Ullah
Zhou Dong
Zekang Ye
Qian Gu
Chuchu Tan
Jiazheng Ma
Jianzhen Teng
Lu Shi
Xiaoxuan Gong
Yong Li
Liang Yuan
Zhihui Xu
Chunjian Li
Department of Cardiology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China
摘要：Dear Editor,
The coronavirus disease 2019(COVID-19)broke out in early December 2019 in Wuhan,China[1],which put tremendous pressure on the medical system.A nationwide lockdown and strict quarantine measures proved effective in reducing the spread of the pandemic.However,it might have affected the management of time-dependent diseases such as ST-elevation myocardial infarction(STEMI)[2].To optimize the treatment of STEMI patients and minimize medical staff contacting COVID-19 in the epidemical regions while preventing and controlling the epidemic,Chinese cardiologists had developed a Chinese Society of Cardiology expert consensus on principles of clinical management of STEMI patients during the COVID-19 epidemic and adjusted the treatment strategy of acute myocardial infarction(AMI)[3-4].
机标关键词：
分类号：R542.2(心脏、血管（循环系）疾病)
论文发表日期：2022-01-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：3( 70-72 )